Literature DB >> 31858814

LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.

Qiang Su1, Yang Liu2, Xiang-Wei Lv1, Ri-Xin Dai1, Xi-Heng Yang1, Bing-Hui Kong3.   

Abstract

Increased production of reactive oxygen species (ROS) significantly contributed to the pathogenesis of acute myocardial infarction (AMI). Recent studies suggest that hypoxia upregulated the long noncoding RNA taurine upregulated gene 1 (TUG1). In this study, we explored the functional significance and molecular mechanisms of TUG1/miR-132-3p axis in ischemia-challenged cardiomyocytes. In primary cardiomyocytes challenged with H2O2, expressions of miR-132-3p, TUG1, and other target proteins were measured by RT quantitative PCR or Western blot analysis; cell viability by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assay; apoptosis by annexin V and propidium iodide staining; the abundance of acetylated H3K9 or histone deacetylase 3 (HDAC3) within the promoter of target genes by chromatin immunoprecipitation; the direct interaction between miR-132-3p and HDAC3 or TUG1 by luciferase reporter assay. The biological significance of miR-132-3p, TUG1, and HDAC3 was assessed using miR-132-3p mimic, siRNA-targeting TUG1 and HDAC3 inhibitor RGF966, respectively, in H2O2-challenged cells in vitro or ischemia-reperfusion (I/R)-induced AMI in vivo. miR-132-3p was downregulated, whereas TUG1 upregulated in H2O2-challenged cardiomyocytes. Overexpressing miR-132-3p or knocking down TUG1 significantly improved viability, inhibited apoptosis, and reduced ROS production in H2O2-stressed cardiomyocytes in vitro and alleviated I/R-induced AMI in vivo. Mechanistically, TUG1 sponged miR-132-3p and upregulated HDAC3, which reduced the acetylation of H3K9 and epigenetically inhibited expressions of antioxidative genes, including Bcl-xL, Prdx2, and Hsp70. The TUG1/miR-132-3p/HDAC3 axis critically regulates ROS production and the pathogenic development of AMI. Targeting TUG1, upregulating miR-132-3p, or inhibiting HDAC3 may benefit AMI treatment.NEW & NOTEWORTHY Increased production of reactive oxygen species (ROS) significantly contributed to the pathogenesis of acute myocardial infarction (AMI). Recent studies suggest that hypoxia upregulated the long noncoding RNA taurine upregulated gene 1 (TUG1). However, the underlying mechanisms remain elusive. In the present study, we reported for the first time that H2O2 or ischemia-reperfusion-induced TUG1, by sponging microRNA 132-3p, activated histone deacetylase 3, which in turn targeted multiple protective genes, stimulated intracellular ROS accumulation, and aggravated the injury of AMI. Our findings might provide some insight to seek new targets for AMI treatment.

Entities:  

Keywords:  HDAC3; TUG1; hypoxia; ischemia-reperfusion; miR-132-3p; reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31858814     DOI: 10.1152/ajpheart.00444.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  24 in total

Review 1.  Evaluating the Role of lncRNAs in the Incidence of Cardiovascular Diseases in Androgenetic Alopecia Patients.

Authors:  Masoumeh Roohaninasab; Shadnaz Fakhteh Yavari; Motahareh Babazadeh; Rozita Adldoosti Hagh; Mahboubeh Pazoki; Mehran Amrovani
Journal:  Cardiovasc Toxicol       Date:  2022-05-04       Impact factor: 3.231

2.  Possible implication of miR-142-3p in coronary microembolization induced myocardial injury via ATXN1L/HDAC3/NOL3 axis.

Authors:  Yuli Xu; Xiangwei Lv; Ruping Cai; Yanling Ren; Shirong He; Wei Zhang; Quanzhong Li; Xiheng Yang; Rixin Dai; Riming Wei; Qiang Su
Journal:  J Mol Med (Berl)       Date:  2022-04-12       Impact factor: 4.599

3.  LncRNA TUG1 aggravates cardiomyocyte apoptosis and myocardial ischemia/reperfusion injury.

Authors:  Dongliang Fu; Tong Gao; Mengru Liu; Chunyan Li; Haiwei Li; Hong Jiang; Xianlun Fu
Journal:  Histol Histopathol       Date:  2021-10-20       Impact factor: 2.303

4.  Diagnostic and Prognostic Value of Deregulated Circulating Long Non-coding RNA TUG1 in Elderly Patients with Severe Pneumonia.

Authors:  Kai Gong; Jiao Xu; Jianlei Tang
Journal:  Inflammation       Date:  2022-09-15       Impact factor: 4.657

Review 5.  Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Cheng; Hongli Li; Shan Hui; Zheyu Zhang; Yang Xiao; Weijun Peng
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

6.  The Protective Role of Bmal1-Regulated Autophagy Mediated by HDAC3/SIRT1 Pathway in Myocardial Ischemia/Reperfusion Injury of Diabetic Rats.

Authors:  Zhen Qiu; Hao Ming; Yi Zhang; Yanli Yu; Shaoqing Lei; Zhong-Yuan Xia
Journal:  Cardiovasc Drugs Ther       Date:  2021-02-23       Impact factor: 3.727

Review 7.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

8.  Therapeutic Effect of Electronic Endoscopic Hematoma Removal on Hypertensive Basal Ganglia Cerebral Hemorrhage Based on Smart Medical Technology.

Authors:  Yiping Wu; Shan Zhang; Yu Dong; Xiangzhu Shen; Yafei Han; Yimeng Li; Wei Xu; Ke Ma; Huichang Tang; Dezhen Yang; Haichang Li
Journal:  J Healthc Eng       Date:  2021-06-08       Impact factor: 2.682

9.  LncRNAs Participate in Post-Resuscitation Myocardial Dysfunction Through the PI3K/Akt Signaling Pathway in a Rat Model of Cardiac Arrest and Cardiopulmonary Resuscitation.

Authors:  Jingying Hou; Chaotao Zeng; Guanghui Zheng; Lian Liang; Longyuan Jiang; Zhengfei Yang
Journal:  Front Physiol       Date:  2021-06-14       Impact factor: 4.755

Review 10.  Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential.

Authors:  Yi Wang; Jinghai Chen; Douglas B Cowan; Da-Zhi Wang
Journal:  Semin Cell Dev Biol       Date:  2021-07-17       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.